Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.44
+0.04 (0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
10.43
-0.01 (-0.10%)
After-hours: Apr 28, 2026, 7:10 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.59 billion as of April 28, 2026. Its market cap has decreased by -36.29% in one year.
Market Cap
3.59B
Enterprise Value
3.93B
1-Year Change
-36.29%
Ranking
Category
Stock Price
$10.44
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.59B, an increase of 3,010.12%. That is a compound annual growth rate of 50.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.96B |
| Veradermics | 3.95B |
| ACADIA Pharmaceuticals | 3.85B |
| Travere Therapeutics | 3.83B |
| Viking Therapeutics | 3.80B |
| Oruka Therapeutics | 3.74B |
| Catalyst Pharmaceuticals | 3.59B |
| Tango Therapeutics | 3.55B |